THE PREVALENCE OF HERBAL AND OVER THE COUNTER MEDICINE USE AMONGST COMMUNITY DWELLING CASE MANAGED OLDER ADULTS LISK C, SPEAR F, CLEM C, JONES C, NORMAN.

Slides:



Advertisements
Similar presentations
UGA Doctor of Pharmacy Candidate
Advertisements

Evaluation of HIV status and its spread in HIV patients on RRT and their spouses Dr. Aditya Agarwal Clinical Fellow Indraprastha Apollo Hospitals, New.
Concerns in Medication Safety in Regards to the Older Adult Population Stephanie A. Ball, Taylor W. Brickley, Macey F. Davenport, Kelly L. Erexson, Emily.
Polypharmacy Among Older Adults in Tehran Tehran University of Medical Sciences, School of Public Health, Islamic Republic of Iran Ahmadi, Batoul, Pharm.
Measuring the Severity of Medication Discrepancies: A Community Pharmacy Perspective.
Collecting data in clinic.  Aim of BADBIR  Definition of Adverse Events  Adverse events in BADBIR  Adverse event recording in hospital case notes.
Obesity –Pharmacological treatments. Dietary management –A low energy,low fat diet is the most effective lifestyle intervention for weight loss Exercise.
Medicine, Age, and Your Brain 1 A presentation by:
Patient Population Nursing-Pharmacy Collaboration on Medication Reconciliation: A Novel Approach to Information Management Michelle Silas MPH, BSN, RN,
EVALUATING THE EFFECTIVENESS OF THE AGS UPDATED 2012 BEERS CRITERIA AS AN EDUCATIONAL TOOL IN A FAMILY MEDICINE RESIDENCY TRAINING PROGRAM Eseoghene Abokede.
PMP Outcomes. Background to Chronic Pain One of the most prevalent physical complaints - defined as prolonged pain of at least 3 months’ duration 10-20%
Using an EHR Template and the Beer’s List to Address Geriatric Polypharmacy Rose Family Medicine Residency Emily Gutgsell, MD Emma Bjore, MD Anna Plunkett,
Grant Macdonald.  Appropriate polypharmacy describes treatment where a patient has multiple morbidities, and/or a complex condition, that is being managed.
Prepared for: The National Consumers League September 20, 2005 J23716 The Use of Oral Anticoagulant Medications: Survey of Physicians: Key Findings.
Community Education Promoting Informed Medicine Use.
Non-Statin Users % (n=247)
Choosing Wisely Pharmacy’s Role and Recommendations Mary Wong
Prescribing for the Oldest Old
The collaborative approach was structured in three phases:
Dental prescription prepared by : Dr.Roba Alagha
USING MEDICINES SAFELY how carers can help
Patient’s experiences of anticancer therapy and opportunities for community pharmacists to support patients with cancer. Fiona MacLean1, Alexander Mullen2,
Percent of Medicare population
Clinical Pharmacists in General Practice
Paula Gardiner MD MPH Boston University Medical School
Copyright © 2016 by Mosby, an imprint of Elsevier Inc.
Presentation for Healthcare Professionals
PECULLIARITIES OF CHRONIC PAIN ASSESSMENT AND MANAGEMENT
Cindy Hatton President & CEO Susan Levitt V.P. Clinical Services/COO
Larissa Grigoryan, MD, PhD Family and Community Medicine
Medication Reconciliation ROP Compliance
POLYPHARMACY IN GERIATRIC PATIENTS Dr SHREYAS MISTRY MD, Dr MAYUR RALI MD HOFSTRA-North Shore LIJ School of Medicine Department of Family Medicine Southside.
School of Physical Therapy METHODS – DATA ANALYSIS
Effects of Medication Therapeutic Effects=Desired or intended effects of medication – refers to the primary purpose of prescribing and administrating medication.
Chapter 19 Mr. Pressman Freshman Health.
Using Medicines Safely (2:50)
Variation in prescribing for type 2 diabetes mellitus in
Comparison of the study findings: Male & female
Vitamin D status and cardio-metabolic risk factors in Saudi Arabia
Canada Needs PAs.
Development of pharmacist prescribing clinics and promoting a positive image of pharmacists in primary care Kerry Steel Rowlands Pharmacy, 29 Mount Oliphant.
CHAPTER 4 Information Management in Pharmacy.
Polypharmacy In Adults: Small Test of Change
Does the Beer’s Criteria Influence Prescribing for Geriatric Patients?
Bonnie Sanderson, PhD, RN
Canada Needs PAs.
What’s New in Medication Management: Focus on Older Adults and Caregivers Tuesday, April 30, :00 Noon CDT Mike Varnell, RPh, CSA (214)
Treating Alcohol Abuse
Information for Network Providers
More Than Treatment.
Patient details Health number: this may be a national identifier (preferred), hospital, clinic, or program number Name: full name is preferable as an accurate.
BEYHAN CENGIZ OZYURT, MD
Canada Needs PAs.
What we don’t know about your medicines can harm you.
Characteristics of Patients who Choose to Participate in a Comprehensive Medication Review (CMR) Program: Implication for Program Structure and Processes.
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Canada Needs PAs.
Canada Needs PAs.
International Nutrition Survey 2011
For Nurses and healthcare providers
Canada Needs PAs.
Adults with Health Problems Who Have an Excellent Patient Experience Report Greater Support to Help Manage Their Health Condition Percent of adults 18–64.
Canada Needs PAs.
Adults with Health Problems Who Have an Excellent Patient Experience Are Most Likely to Be Well-Informed About Their Prescription Medications Percent of.
A CASE MANAGER APPROACH IN MANAGING MULTIMORBIDITY
Perceptions and Knowledge of Storing Medications at Home in Al-Qassim Region, Saudi Arabia Afaf Badr Alenazi, Mansour Saleh Alsharidah, Amal Hassan Al-Najjar,
Chapter 7.5Identify Medications Considered Inappropriate for the Elderly INTRODUCTION – Medication toxic effects and drug-related problems can have profound.
The New Zealand Association of Medical Herbalists (NZAMH)
Asthma, a chronic inflammatory disorder of the airways, is one of the more prevalent chronic conditions in Canada.1 According to the 2009/10 Canadian Community.
Canada Needs PAs.
Presentation transcript:

THE PREVALENCE OF HERBAL AND OVER THE COUNTER MEDICINE USE AMONGST COMMUNITY DWELLING CASE MANAGED OLDER ADULTS LISK C, SPEAR F, CLEM C, JONES C, NORMAN J. GERIATRIC MEDICINE , POTTERS BAR HOSPITAL. Introduction Results An increasingly ageing population is changing the demography of older patients we provide healthcare to. Older people are increasingly taking herbal medicines1 and over the counter medicines for a variety of reasons; treatment of chronic ailments, to help boost memory, prevent illness and aid longevity. Healthcare professionals are often unaware of this. This may result in adverse drug reactions due to interactions between prescribed and herbal medicines. Aim We evaluated the prevalence of herbal and over the counter medication in a cohort of case managed patients with the aim of identifying potential harmful interactions. Methods A questionnaire based survey and database review of all patients managed by the Hertsmere community matrons was undertaken in August 2010. Data was analysed using an Excel database. Results   114 out of 116 patients that were identified took part. 63% were female. Over half of the patients were aged above 80years (fig1). Most patients had 5 or more long term conditions; the majority being cardio-respiratory in nature. Over the counter medication and herbal medicine use accounted for 16.2 % of the total medication burden (fig4). In most cases their primary physician was unaware that they were taking these medications. The majority of over the counter medications were analgesics (27%) followed by vitamins (21%), laxatives (18%) and creams and lotions used for analgesic and skin moistening effects (11%).Cod liver oil, omega 3, antihistamines, antimotility agents, iron and nutritional supplements accounted for 23% with herbal medicine use accounting for only 2% (fig3-4). Of these patients, the range of prescribed medicines they took were 5-9 with 25 potential drug interactions identified. The majority of patients were on at least 10 medications. This study highlights the degree of polypharmacy and potentially significant drug interactions in a cohort of case managed patients. It highlights the importance to healthcare professionals of taking a full drug history as there is increasingly availability of over the counter, herbal and homeopathic medications. Studies on the potential cost savings resulting from addressing polypharmacy are needed. Conclusions